Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A new book shows how Johnson & Johnson has pushed misleading narratives and suppressed inconvenient findings to sell its ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Fruth autoclave bags are manufactured in the U.S. from 100% domestically-sourced resin with industry-leading lead times.

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

The US Department of Health and Human Services is demanding that pharmaceutical companies cut drug prices to the lowest price ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

Following President Trump's Most Favored Nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.

Novotech is a winner in the Diversity, Research and Development, and Marketing categories in the 2025 Pharmaceutical ...

In a world increasingly reliant on biologics and precision medicine, it’s clear that advanced cold storage is not just a ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...